StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/301% above fair value
$0.90+0.09 (+11.12%)

Close on Nov 20, 2026Market cap $39.86MP/E –Yield –

Elutia gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Elutia's gross profit for the twelve months ending Jun 30, 2026 was $7.02M, up 18.0% year over year. For fiscal 2025 it was $6.60M, down 1.8% from the year before. The highest annual figure on record is $20.56M in fiscal 2020.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.60M-1.8%
FY2024Dec 31, 2024$6.72M-39.2%
FY2023Dec 31, 2023$11.05M-5.0%
FY2022Dec 31, 2022$11.64M-38.8%
FY2021Dec 31, 2021$19.02M-7.5%
FY2020Dec 31, 2020$20.56M+4.0%
FY2019Dec 31, 2019$19.77M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.45M-0.4%
Q1 FY2026Mar 31, 2026$1.80M+30.4%
Q4 FY2025Dec 31, 2025$1.91M+44.8%
Q3 FY2025Sep 30, 2025$1.85M+3.5%
Q2 FY2025Jun 30, 2025$1.45M-48.1%
Q1 FY2025Mar 31, 2025$1.38M-51.4%
Q4 FY2024Dec 31, 2024$1.32M-37.8%
Q3 FY2024Sep 30, 2024$1.79M-37.0%
Q2 FY2024Jun 30, 2024$2.80M+3.1%
Q1 FY2024Mar 31, 2024$2.84M-15.7%
Q4 FY2023Dec 31, 2023$2.13M-56.6%
Q3 FY2023Sep 30, 2023$2.84M-33.6%
Q2 FY2023Jun 30, 2023$2.71M-19.9%
Q1 FY2023Mar 31, 2023$3.37M-8.5%
Q2 FY2022Jun 30, 2022$4.90M-12.8%
Q1 FY2022Mar 31, 2022$4.28M-32.4%
Q4 FY2021Dec 31, 2021$3.39M-43.7%
Q3 FY2021Sep 30, 2021$3.69M-33.4%
Q2 FY2021Jun 30, 2021$5.61M+48.4%
Q1 FY2021Mar 31, 2021$6.33M+21.4%
Q4 FY2020Dec 31, 2020$6.02M+23.1%
Q3 FY2020Sep 30, 2020$5.54M-0.0%
Q2 FY2020Jun 30, 2020$3.78M–
Q1 FY2020Mar 31, 2020$5.22M–
Q4 FY2019Dec 31, 2019$4.89M–
Q3 FY2019Sep 30, 2019$5.54M–

More Elutia figures

See a number that looks wrong?